Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from ...

Cybin Inc. is upgraded to Buy, driven by recent regulatory and clinical tailwinds that favor its lead candidate, HLP003.

CNS stimulants vs nonstimulants were associated with improved clinical outcomes in youths with ADHD, internalizing disorders, and comorbid disruptive mood dysregulation disorder.

President Trump's executive order is giving psychedelic stocks a boost. These companies are leaders in the industry.

But after LSD spread into the larger culture, the U.S. government imposed strict restrictions on it (Dyck, 2008). By 1966, it ...

Hidradenitis suppurativa (HS) is a chronic inflammatory HS skin disease that most people have never heard of – yet it affects ...

U.S. President Donald Trump this week signed an executive order directing health regulators to speed reviews of psychedelic ...

Experts say President Trump's order, paving the way for scientists to study psychedelic drugs for mental health treatment, ...

The order calls for the FDA to give expedited consideration to certain psychedelic drugs.

Texas lawmakers are eyeing clinical trial for ibogaine as President Trump signed an executive order to speed up research into ...

The President has cleared the way for research into new mental-health treatments - but experts urge caution ...

Opinion: President Trump’s executive order on psychedelic medication signals a potential shift in how America approaches ...